pharmaceutical manufacturing
- H
Pharmaceuticals: India's Expanding Role in Global Healthcare
India’s Pharmaceutical Industry Strengthens Global Position, Eyes $130 Billion Market by 2030 Sector Ranks Third Globally by Volume with Expanding Manufacturing Base New Delhi, March 21: India’s pharmaceutical industry continues to solidify its position as a globally integrated and...- Himanshu
- Thread
- active pharmaceutical ingredients (apis) domestic production economic survey generic medicines healthcare supply networks india market size pharmaceutical exports pharmaceutical industry pharmaceutical manufacturing pharmaceutical market trade agreements unicef usfda vaccine supply world health organization (who)
- Replies: 0
- Forum: Business
- K
Cipla Recalls Anti-Cancer Drug Nilotinib Due to Manufacturing Issue
Cipla’s US Arm Recalls Over 400 Cartons of Generic Anti Cancer Drug Nilotinib: USFDA Manufacturing Issue Triggers Recall of Nilotinib Capsules in Two Strengths New Delhi, March 8: Cipla’s US-based subsidiary has recalled more than 400 cartons of a generic anti cancer medication from the United...- Karthik
- Thread
- anti-cancer medicine cancer treatment cipla generic medicine generics market india manufacturing issue nilotinib pharmaceutical industry pharmaceutical manufacturing pharmaceutical recall sun pharmaceutical industries united states us food and drug administration (usfda) warren, new jersey
- Replies: 0
- Forum: Business
- K
Aurobindo Pharma Shares Rise 2% After USFDA Final Approval for Everolimus Tablets
Shares of Aurobindo Pharma Ltd. gained as much as 2% on Thursday, February 26, after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration for Everolimus Tablets.The approval allows Eugia Unit I to...- Karthik
- Thread
- anda approval aurobindo pharma eugia pharma specialities european revenue growth everolimus tablets generic drugs iqvia market data kidney transplant liver transplant oncology drugs organ transplantation pharmaceutical manufacturing pharmaceutical sales research and development us food and drug administration
- Replies: 0
- Forum: Stocks
- K
CDSCO Audits Over 90% of Cough Syrup Manufacturers, Aims to Eliminate Quality Issues by Next Season
1,250 Manufacturing Sites Inspected Under Risk Based Framework Mumbai, February 23: The Central Drugs Standard Control Organisation has completed audits of more than 90 per cent of cough syrup manufacturers across the country, as part of an intensified quality compliance drive. A senior official...- Karthik
- Thread
- audit capa (corrective and preventive action) central drugs standard control organisation cough syrup drugs controller general of india good manufacturing practices india mumbai pharmaceutical industry pharmaceutical manufacturing pharmaceutical quality quality control regulatory compliance risk-based inspection
- Replies: 0
- Forum: Business
- K
Aurobindo Pharma to Boost Penicillin G Output Beyond 10,000 MT Annually, Targets 20 to 21% EBITDA Margin in FY26
Penicillin G Expansion Gains Momentum in Kakinada SEZ Aurobindo Pharma is stepping up its Penicillin G production, with plans to manufacture more than 10,000 metric tonnes annually over the next 12 months, according to Chief Financial Officer S Subramanian.The Hyderabad-based pharmaceutical... - K
Alkem Laboratories Receives USFDA Form 483 with Six Observations After Chakan Facility Inspection
USFDA Concludes Pre Approval Inspection at Enzene Biosciences Unit New Delhi, February 16: Alkem Laboratories on Monday said the United States health regulator has issued a Form 483 with six observations following an inspection of the manufacturing facility of its wholly owned subsidiary Enzene...- Karthik
- Thread
- alkem laboratories bse chakan data integrity drug firm enzene biosciences fd&c act form 483 india manufacturing unit pharmaceutical industry pharmaceutical manufacturing quality systems regulatory inspection us food and drug administration (usfda)
- Replies: 0
- Forum: Order & deals